Extending molecular insights beyond DNA and RNA to realize new value in existing FFPE tissue biobanks.
A look at how AI-driven, multi-omics platforms are advancing the discovery and development of precision medicines.
Unlocking functional biology, new biomarker insights, and responder profiles from archived trial samples.
Using TAA profiling to identify differentially expressed, disease-modifying, tractable targets on the cell surface.
Delivering quantitative, reproducible protein measures for rapid proof-of-mechanism & target engagement insights.
Using multi-omics to characterize changes in inflammatory markers observed following GLP-1 therapy.
Transforming archival tissue into a discovery-ready resource to move from target discovery to functional validation, in weeks.
We explore known & novel associations of creatinine using Sapient’s DynamiQ™ Insights Engine. See what we find.
Enabling measure of 10K+ proteins in FFPE tissue & tumors and multi-omic molecular mapping of tumor biology.
Unlocking functional tumor biology from FFPE tissue – quantitatively, reproducibly, and at scale.
Sharing analytical strategies to ensure omics datasets generate insights that are both truthful & actionable.
The innovations enhance how MS data is processed, filtered & interpreted across large-scale biological datasets.
